Diabetes and arterial stiffening.

Area of Science:

• Cardiovascular Science
• Endocrinology
• Gerontology

Background:

• Type 2 diabetes (DM-2) is a growing global health concern, linked to obesity and population aging.
• Arterial stiffening is prevalent in diabetes (type 1 and DM-2), impaired glucose metabolism, and metabolic syndrome.
• Aging also contributes to arterial stiffening by altering aortic elastin and collagen composition.

Purpose of the Study:

• To explore the mechanisms and consequences of arterial stiffening in type 2 diabetes.
• To review current and potential therapeutic strategies for mitigating arterial stiffening.

Main Methods:

• Literature review and synthesis of existing studies on diabetes, aging, and arterial mechanics.
• Analysis of pathophysiological pathways linking metabolic dysfunction to vascular changes.

Main Results:

• Arterial stiffening in DM-2 is associated with hyperglycemia, dyslipidemia, and hypertension.
• These factors promote insulin resistance, oxidative stress, endothelial dysfunction, and inflammation.
• Consequences include elevated pulse pressure, hypertension, and increased cardiovascular disease risk.

Conclusions:

• Arterial stiffening is a significant complication of type 2 diabetes and aging.
• Pharmacological interventions targeting the renin-angiotensin-aldosterone system, vascular smooth muscle, nitric oxide, and advanced glycosylation end-products show promise.
• Fish oil supplementation is also a potential therapeutic avenue.